Omega Healthcare Investors Files 8-K on Financials

Ticker: OHI · Form: 8-K · Filed: 2024-08-01T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, results-of-operations, real-estate-investment-trusts

TL;DR

Omega Healthcare Investors dropped an 8-K on Aug 1st covering their financials. Check it out.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on August 1, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the report date and date of change both listed as August 1, 2024. The company is a Maryland-incorporated real estate investment trust based in Hunt Valley, Maryland.

Why It Matters

This 8-K filing provides crucial updates on Omega Healthcare Investors' financial performance and operational results, which can impact investor decisions and market perception.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate or significant risks.

Key Players & Entities

FAQ

What specific financial information is being reported in this 8-K filing?

The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.

When was the earliest event reported in this filing?

The earliest event reported is dated August 1, 2024.

What is the principal executive office address for Omega Healthcare Investors, Inc.?

The principal executive offices are located at 303 International Circle, Suite 200, Hunt Valley, Maryland 21030.

Under which section of the Securities Exchange Act of 1934 is this report filed?

This Current Report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

What is the Commission File Number for Omega Healthcare Investors, Inc.?

The Commission File Number is 001-11316.

From the Filing

0000888491-24-000034.txt : 20240801 0000888491-24-000034.hdr.sgml : 20240801 20240801162128 ACCESSION NUMBER: 0000888491-24-000034 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240801 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 241167056 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 ohi-20240801x8k.htm 8-K 0000888491 false 0000888491 2024-08-01 2024-08-01 ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ​ ​ ​ ​ ​ ​ FORM 8-K ​ ​ ​ ​ ​ ​ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ​ Date of Report (Date of earliest event reported): August 1, 2024 ​ OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter) ​ Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) ​ 303 International Circle, Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code) ​ ( 410 ) 427-1700 (Registrant’s telephone number, including area code) ​ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act. ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934: ​ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.10 par value OHI New York Stock Exchange ​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ​ Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ​ ​ Item 2.02     Regulation FD Disclosure ​ On August 1, 2024, Omega Healthcare Investors, Inc. (“Omega”) issued a press release regarding its financial results for the quarter ended June 30, 2024. Omega’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. ​ The information in this Item 2.02 of this Current Report on Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or othe

View on Read The Filing